SEC 13F Intelligence

Managers / Q3 2023 · view latest →

SYQUANT CAPITAL SAS

CIK 0001766392 · 25 AVENUE KLEBER, PARIS, I0, 75116 · 0033142569307

Reported Value
$255M
Q3 2023
Positions
9
Filings on Record
32
2019–present window
Filed
Oct 12, 2023
original filing

Summary

Syquant Capital Sas reported $255M in U.S.-listed holdings across 9 positions for Q3 2023.

The portfolio is heavily concentrated: Horizon Therapeutics Pub L alone accounts for 63.5% of reported value.

Compared with Q2 2023, the fund opened 8 new positions and exited 10.

Portfolio Metrics

Turnover
+25.4%
vs prior filed quarter
Largest Position
+63.5%
Horizon Therapeutics Pub L
New / Exited
8 / 10
positions this quarter

Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.

Reported Value by Quarter

13F Reported Value
Q4 ’18: $117MQ4 ’18Q1 ’19: $258MQ2 ’19: $312MQ3 ’19: $365MQ4 ’19: $194MQ4 ’19Q1 ’20: $407MQ2 ’20: $215MQ3 ’20: $196MQ4 ’20: $387MQ4 ’20Q1 ’21: $386MQ2 ’21: $83MQ3 ’21: $164MQ4 ’21: $262MQ4 ’21Q1 ’22: $195MQ2 ’22: $90MQ3 ’22: $165MQ4 ’22: $41MQ4 ’22Q1 ’23: $43MQ2 ’23: $138MQ3 ’23: $255MQ4 ’23: $22MQ4 ’23Q1 ’24: $64MQ2 ’24: $10MQ3 ’24: $27MQ4 ’24: $70MQ4 ’24Q1 ’25: $141MQ2 ’25: $302MQ3 ’25: $348MQ4 ’25: $817MQ4 ’25Q1 ’26: $640MQ2 ’26: $447Mfilingsflow.com

Portfolio Composition

By security type
Other: 63.5%Common Stock: 35.7%US DOMESTIC: 0.8%
  • Other · 63.5% · $162M
  • Common Stock · 35.7% · $91M
  • US DOMESTIC · 0.8% · $2M

Quarter-over-Quarter Changes full breakdown →

vs Q2 2023 (amended baseline)

IssuerMoveShare ΔShares nowValue ΔValue now
ACTIVISION BLIZZARD INCNEW+763.2K763.2K+$71M$71M
HOSTESS BRANDS INCNEW+183.1K183.1K+$6M$6M
CPRICAPRI HOLDINGS LIMITEDNEW+113.6K113.6K+$6M$6M
NATIONAL INSTRS CORPNEW+53.3K53.3K+$3M$3M
SEAGEN INCNEW+14.0K14.0K+$2M$2M
INTERCEPT PHARMACEUTICALS INNEW+2.00M2.00M+$2M$2M
ARMKARAMARKNEW+34.3K34.3K+$1M$1M
PHINPHINIA INCNEW+29.6K29.6K+$793,000$793,000

Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.

Holdings — Q3 2023

9 positions
Export to Excel
#IssuerClass% PortfolioValue ↓Shares
1HORIZON THERAPEUTICS PUB LSHS63.55%$162M1.40M
2ACTIVISION BLIZZARD INCCOM28.06%$71M763.2K
3HOSTESS BRANDS INCCL A2.39%$6M183.1K
4CPRICAPRI HOLDINGS LIMITEDhistory →SHS2.35%$6M113.6K
5NATIONAL INSTRS CORPCOM1.25%$3M53.3K
6SEAGEN INCCOM0.86%$2M14.0K
7INTERCEPT PHARMACEUTICALS INNOTE 2.000% 5/10.77%$2M2.00M
8ARMKARAMARKCOM0.47%$1M34.3K
9PHINPHINIA INCCOMMON STOCK0.31%$793,00029.6K

Filing History

QuarterReported ValuePositionsFiledTypeLinks
Q2 2026$447M38Jul 9, 202613F-HRchanges · EDGAR ↗
Q1 2026$640M40Apr 10, 202613F-HRchanges · EDGAR ↗
Q4 2025$817M37Jan 13, 202613F-HRchanges · EDGAR ↗
Q3 2025$348M17Oct 28, 202513F-HRchanges · EDGAR ↗
Q2 2025$302M14Jul 18, 2025RESTATEMENTchanges · EDGAR ↗
Q1 2025$141M14Apr 23, 202513F-HRchanges · EDGAR ↗
Q4 2024$70M6Jan 13, 202513F-HRchanges · EDGAR ↗
Q3 2024$27M5Oct 4, 202413F-HRchanges · EDGAR ↗
Q2 2024$10M5Jul 10, 202413F-HRchanges · EDGAR ↗
Q1 2024$64M6Apr 9, 202413F-HRchanges · EDGAR ↗
Q4 2023$22M7Jan 10, 202413F-HRchanges · EDGAR ↗
Q3 2023$255M9Oct 12, 202313F-HRchanges · EDGAR ↗
Q2 2023$138M11Jul 10, 202313F-HRchanges · EDGAR ↗
Q1 2023$43M7Apr 12, 202313F-HRchanges · EDGAR ↗
Q4 2022$41M14Jan 17, 202313F-HRchanges · EDGAR ↗
Q3 2022$165M25Oct 11, 202213F-HRchanges · EDGAR ↗
Q2 2022$90M32Jul 8, 202213F-HRchanges · EDGAR ↗
Q1 2022$195M35Apr 7, 202213F-HRchanges · EDGAR ↗
Q4 2021$262M43Jan 12, 202213F-HRchanges · EDGAR ↗
Q3 2021$164M42Oct 14, 202113F-HRchanges · EDGAR ↗
Q2 2021$83M41Jul 14, 202113F-HRchanges · EDGAR ↗
Q1 2021$386M53Apr 20, 202113F-HRchanges · EDGAR ↗
Q4 2020$387M81Feb 5, 202113F-HRchanges · EDGAR ↗
Q3 2020$196M62Oct 21, 202013F-HRchanges · EDGAR ↗
Q2 2020$215M23Aug 5, 202013F-HRchanges · EDGAR ↗
Q1 2020$407M18Apr 14, 202013F-HRchanges · EDGAR ↗
Q4 2019$194M16Jan 8, 202013F-HRchanges · EDGAR ↗
Q3 2019$365M17Oct 17, 201913F-HRchanges · EDGAR ↗
Q2 2019$312M14Jul 5, 201913F-HRchanges · EDGAR ↗
Q1 2019$258M15Apr 12, 201913F-HRchanges · EDGAR ↗
Q4 2018$117M11Feb 4, 201913F-HRchanges · EDGAR ↗

13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.